Revenue
2013
2014
2015
2016
2017
2018
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M | $0 | — | — | — | — | — | $0 | $0 | $0 | $3,856 | $8,347 | $122,319 | $252,361 | $569,845 | $672,755 |
| Gross profit | $588,932 | $0 | — | — | — | — | — | — | — | $49 | $3,816 | $5,248 | $78,891 | $217,529 | $217,091 | $314,985 |
| Research & development | — | — | — | — | — | — | — | — | — | — | $0 | $341 | $60,878 | $108,408 | $159,196 | $162,245 |
| Operating expenses | $761,035 | $1.6M | $1.5M | $1.5M | — | — | — | — | — | — | $238,784 | $53,487 | $198,021 | $328,046 | $489,301 | $652,364 |
| Operating income | −$172,103 | −$1.6M | −$1.5M | −$1.5M | −$2.0M | −$2.8M | −$1.8M | −$4.1M | −$12.7M | −$3.4M | −$234,968 | −$48,239 | −$119,130 | −$110,517 | −$272,210 | −$337,379 |
| Net income | −$69.3M | −$1.2M | −$9.3M | −$6.9M | −$2.7M | −$6.5M | −$4.9M | −$7.9M | −$14.6M | −$6.1M | −$346,742 | −$24,349 | −$173,132 | −$207,789 | −$357,251 | −$400,227 |
| Basic EPSper diluted share | — | — | — | -$0.04 | -$0.02 | -$0.05 | -$0.04 | -$0.06 | -$0.13 | -$0.07 | -$1.88 | $0.00 | -$0.01 | -$0.01 | -$0.02 | -$0.02 |
| Diluted EPSper diluted share | $0.34 | $0.01 | -$0.05 | — | — | -$0.05 | -$0.04 | -$0.06 | -$0.13 | -$0.07 | -$1.88 | $0.00 | -$0.01 | -$0.01 | -$0.02 | -$0.02 |